Ju Li Selected Research

Brentuximab Vedotin

2/2024

Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ju Li Research Topics

Disease

14	Neoplasms (Cancer) 05/2024 - 03/2002
8	COVID-19 07/2021 - 04/2020
7	Inflammation (Inflammations) 03/2023 - 01/2017
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2022 - 01/2017
5	Pain (Aches) 02/2024 - 10/2008
5	Hemorrhage 01/2020 - 03/2013
5	Necrosis 12/2016 - 11/2004
4	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2002
4	Osteoarthritis 02/2024 - 10/2013
4	Intervertebral Disc Degeneration 01/2023 - 06/2021
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2017
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024 - 09/2013
3	Rheumatoid Arthritis 03/2023 - 01/2021
3	Arthritis (Polyarthritis) 01/2023 - 01/2018
3	Body Weight (Weight, Body) 08/2022 - 01/2020
3	Shock 05/2022 - 01/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013 - 08/2011
3	Crohn Disease (Crohn's Disease) 09/2009 - 01/2007
2	Asthma (Bronchial Asthma) 03/2024 - 01/2015
2	Muscle Weakness 01/2023 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 03/2020
2	Dermatomyositis (Dermatopolymyositis) 01/2023 - 01/2018
2	Hemophilia A (Haemophilia) 08/2022 - 07/2022
2	Carcinogenesis 06/2022 - 10/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 09/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2019 - 04/2017
2	Liver Neoplasms (Liver Cancer) 02/2018 - 12/2013
2	Osteoporotic Fractures 01/2016 - 03/2014
2	Infections 06/2013 - 06/2007
2	Pre-Eclampsia (Preeclampsia) 08/2011 - 05/2007
2	Fibrosis (Cirrhosis) 05/2010 - 11/2004
1	Lymphatic Metastasis 05/2024
1	Neoplasm Metastasis (Metastasis) 05/2024
1	Thrombocytopenia (Thrombopenia) 05/2024
1	Halitosis 03/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Eye Diseases (Eye Disease) 01/2023

Drug/Important Bio-Agent (IBA)

7	Inosine Triphosphate (ITP)IBA 07/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2010
4	MicroRNAs (MicroRNA)IBA 03/2023 - 05/2019
4	CytokinesIBA 07/2022 - 09/2019
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2011 - 01/2007
3	Lenalidomide (CC 5013)FDA Link 09/2013 - 08/2011
3	Adalimumab (Humira)FDA Link 09/2009 - 01/2007
2	Protons (Proton)IBA 04/2024 - 07/2022
2	Prednisone (Sone)FDA LinkGeneric 02/2024 - 11/2004
2	romidepsin (FK228)FDA Link 02/2024 - 01/2022
2	C-Reactive ProteinIBA 01/2023 - 11/2022
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2023 - 06/2014
2	AntibodiesIBA 01/2023 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 01/2018
2	Amygdalin (Laetrile)IBA 01/2023 - 01/2020
2	perovskiteIBA 07/2022 - 05/2022
2	delphinidinIBA 06/2022 - 10/2019
2	Anthocyanins (Anthocyanin)IBA 06/2022 - 10/2019
2	OxidesIBA 05/2022 - 09/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 09/2019
2	AlloysIBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2002
2	artemisinin-naphthoquine combinationIBA 12/2016 - 07/2014
2	TantalumIBA 12/2016 - 08/2013
2	Hemostatics (Antihemorrhagics)IBA 12/2016 - 03/2013
2	LigandsIBA 03/2015 - 02/2012
2	Sodium Glutamate (Accent)IBA 08/2011 - 05/2007
2	Monoclonal AntibodiesIBA 09/2009 - 01/2007
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024
1	Transferrin (beta 2 Transferrin)IBA 05/2024
1	serum P-component (CIt)IBA 05/2024
1	AlbuminsIBA 05/2024
1	AmidesIBA 04/2024
1	Sulfur Compounds (Compounds, Sulfur)IBA 03/2024
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 03/2024
1	liquiritinIBA 02/2024
1	Brentuximab VedotinIBA 02/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024
1	Vincristine (Oncovin)FDA LinkGeneric 02/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2023
1	Branched-Chain Amino AcidsIBA 11/2023
1	EnzymesIBA 03/2023
1	ImmunosorbentsIBA 03/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023

Therapy/Procedure

7	Personal Protective Equipment 07/2021 - 04/2020
6	Therapeutics 01/2023 - 06/2007
4	N95 Respirators 07/2021 - 04/2020
4	Mechanical Ventilators (Ventilator) 07/2021 - 04/2020
3	Drug Therapy (Chemotherapy) 05/2024 - 01/2023
3	Transplantation 01/2019 - 05/2010
3	Stem Cell Transplantation 01/2019 - 09/2013
2	Perioperative Period 07/2022 - 10/2013
2	Respiratory Protective Devices (Gas Mask) 03/2021 - 01/2021
2	Electrodes (Electrode) 02/2020 - 12/2010
2	Laser Therapy (Surgery, Laser) 05/2018 - 01/2018
2	Hepatectomy 02/2018 - 12/2013
2	Decompression 12/2016 - 10/2008
1	Immunotherapy 01/2023